SHORT VERSUS TWELVE MONTHS OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTS IMPLANTATION: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

The benefits of 12 months of dual antiplatelet therapy (DAPT) as compared with short-term (≤ 6 months), in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) remains controversial. We performed a meta-analysis of 1-year versus short-term duration DAPT in